Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 75

1.

Evaluating the use of whole genome sequencing for the investigation of a large mumps outbreak in Ontario, Canada.

Stapleton PJ, Eshaghi A, Seo CY, Wilson S, Harris T, Deeks SL, Bolotin S, Goneau LW, Gubbay JB, Patel SN.

Sci Rep. 2019 Aug 30;9(1):12615. doi: 10.1038/s41598-019-47740-1.

2.

Early imaging predictors of long-term outcomes in relapse-onset multiple sclerosis.

Brownlee WJ, Altmann DR, Prados F, Miszkiel KA, Eshaghi A, Gandini Wheeler-Kingshott CAM, Barkhof F, Ciccarelli O.

Brain. 2019 Aug 1;142(8):2276-2287. doi: 10.1093/brain/awz156.

PMID:
31342055
3.

Periventricular magnetisation transfer ratio abnormalities in multiple sclerosis improve after alemtuzumab.

Brown JWL, Prados Carrasco F, Eshaghi A, Sudre CH, Button T, Pardini M, Samson RS, Ourselin S, Wheeler-Kingshott CAG, Jones JL, Coles AJ, Chard DT.

Mult Scler. 2019 Jun 6:1352458519852093. doi: 10.1177/1352458519852093. [Epub ahead of print]

PMID:
31169059
4.

Applying causal models to explore the mechanism of action of simvastatin in progressive multiple sclerosis.

Eshaghi A, Kievit RA, Prados F, Sudre CH, Nicholas J, Cardoso MJ, Chan D, Nicholas R, Ourselin S, Greenwood J, Thompson AJ, Alexander DC, Barkhof F, Chataway J, Ciccarelli O.

Proc Natl Acad Sci U S A. 2019 May 28;116(22):11020-11027. doi: 10.1073/pnas.1818978116. Epub 2019 May 9.

5.

Magnetisation transfer ratio abnormalities in primary and secondary progressive multiple sclerosis.

Brown JWL, Chowdhury A, Kanber B, Prados Carrasco F, Eshaghi A, Sudre CH, Pardini M, Samson RS, van de Pavert SH, Wheeler-Kingshott CG, Chard DT.

Mult Scler. 2019 Apr 8:1352458519841810. doi: 10.1177/1352458519841810. [Epub ahead of print]

PMID:
30957691
6.

Evolution of regional brain atrophy in children with multiple sclerosis: Gray matters.

Yeh EA, Eshaghi A.

Neurology. 2019 Apr 9;92(15):694-695. doi: 10.1212/WNL.0000000000007254. Epub 2019 Mar 13. No abstract available.

PMID:
30867265
7.

DIVE: A spatiotemporal progression model of brain pathology in neurodegenerative disorders.

Marinescu RV, Eshaghi A, Lorenzi M, Young AL, Oxtoby NP, Garbarino S, Crutch SJ, Alexander DC; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2019 May 15;192:166-177. doi: 10.1016/j.neuroimage.2019.02.053. Epub 2019 Mar 4.

PMID:
30844504
8.

The first Canadian pediatric case of extensively drug-resistant Salmonella Typhi originating from an outbreak in Pakistan and its implication for empiric antimicrobial choices.

Wong W, Rawahi HA, Patel S, Yau Y, Eshaghi A, Zittermann S, Tattum L, Morris SK.

IDCases. 2019 Jan 15;15:e00492. doi: 10.1016/j.idcr.2019.e00492. eCollection 2019.

9.

Clinical relevance of cortical network dynamics in early primary progressive MS.

Tur C, Kanber B, Eshaghi A, Altmann DR, Khaleeli Z, Prados F, Ourselin S, Thompson AJ, Gandini Wheeler-Kingshott CA, Toosy AT, Ciccarelli O.

Mult Scler. 2019 Feb 25:1352458519831400. doi: 10.1177/1352458519831400. [Epub ahead of print]

10.

Nosocomial outbreak of vanD-carrying vancomycin-resistant Enterococcus faecium.

Lam PW, Kozak RA, Eshaghi A, Avaness M, Salt N, Patel SN, Simor AE, Leis JA.

Infect Control Hosp Epidemiol. 2018 Oct;39(10):1266-1268. doi: 10.1017/ice.2018.174. Epub 2018 Aug 16. No abstract available.

PMID:
30111383
11.

Structural cortical network reorganization associated with early conversion to multiple sclerosis.

Tur C, Eshaghi A, Altmann DR, Jenkins TM, Prados F, Grussu F, Charalambous T, Schmidt A, Ourselin S, Clayden JD, Wheeler-Kingshott CAMG, Thompson AJ, Ciccarelli O, Toosy AT.

Sci Rep. 2018 Jul 16;8(1):10715. doi: 10.1038/s41598-018-29017-1.

12.

Laboratory testing and phylogenetic analysis during a mumps outbreak in Ontario, Canada.

L'Huillier AG, Eshaghi A, Racey CS, Ogbulafor K, Lombos E, Higgins RR, Alexander DC, Kristjanson E, Maregmen J, Gubbay JB, Mazzulli T.

Virol J. 2018 Jun 5;15(1):98. doi: 10.1186/s12985-018-0996-5.

13.

Progression of regional grey matter atrophy in multiple sclerosis.

Eshaghi A, Marinescu RV, Young AL, Firth NC, Prados F, Jorge Cardoso M, Tur C, De Angelis F, Cawley N, Brownlee WJ, De Stefano N, Laura Stromillo M, Battaglini M, Ruggieri S, Gasperini C, Filippi M, Rocca MA, Rovira A, Sastre-Garriga J, Geurts JJG, Vrenken H, Wottschel V, Leurs CE, Uitdehaag B, Pirpamer L, Enzinger C, Ourselin S, Gandini Wheeler-Kingshott CA, Chard D, Thompson AJ, Barkhof F, Alexander DC, Ciccarelli O.

Brain. 2018 Jun 1;141(6):1665-1677. doi: 10.1093/brain/awy088.

14.

Prevalence of vancomycin-variable Enterococcus faecium (VVE) among vanA-positive sterile site isolates and patient factors associated with VVE bacteremia.

Kohler P, Eshaghi A, Kim HC, Plevneshi A, Green K, Willey BM, McGeer A, Patel SN; Toronto Invasive Bacterial Diseases Network (TIBDN).

PLoS One. 2018 Mar 22;13(3):e0193926. doi: 10.1371/journal.pone.0193926. eCollection 2018.

15.

Use of Genome Sequencing to Define Institutional Influenza Outbreaks, Toronto, Ontario, Canada, 2014-15.

MacFadden DR, McGeer A, Athey T, Perusini S, Olsha R, Li A, Eshaghi A, Gubbay JB, Hanage WP.

Emerg Infect Dis. 2018 Mar;24(3):492-497. doi: 10.3201/eid2403.171499.

16.

Deep gray matter volume loss drives disability worsening in multiple sclerosis.

Eshaghi A, Prados F, Brownlee WJ, Altmann DR, Tur C, Cardoso MJ, De Angelis F, van de Pavert SH, Cawley N, De Stefano N, Stromillo ML, Battaglini M, Ruggieri S, Gasperini C, Filippi M, Rocca MA, Rovira A, Sastre-Garriga J, Vrenken H, Leurs CE, Killestein J, Pirpamer L, Enzinger C, Ourselin S, Wheeler-Kingshott CAMG, Chard D, Thompson AJ, Alexander DC, Barkhof F, Ciccarelli O; MAGNIMS study group.

Ann Neurol. 2018 Feb;83(2):210-222. doi: 10.1002/ana.25145. Epub 2018 Feb 6.

17.

Visual and Anatomical Outcomes of Spironolactone Therapy in Patients with Chronic Central Serous Chorioretinopathy.

Falavarjani KG, Amirsardari A, Habibi A, Eshaghi A, Bakhti S, Aghdam KA.

J Ophthalmic Vis Res. 2017 Jul-Sep;12(3):281-289. doi: 10.4103/jovr.jovr_139_16.

18.

Influence of nationality on the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS).

Smerbeck A, Benedict RHB, Eshaghi A, Vanotti S, Spedo C, Blahova Dusankova J, Sahraian MA, Marques VD, Langdon D.

Clin Neuropsychol. 2018 Jan;32(1):54-62. doi: 10.1080/13854046.2017.1354071. Epub 2017 Jul 19.

PMID:
28721748
19.

Author response: Gray matter MRI differentiates neuromyelitis optica from multiple sclerosis using random forest.

Eshaghi A, Ciccarelli O.

Neurology. 2017 May 9;88(19):1875. doi: 10.1212/WNL.0000000000003930. No abstract available.

PMID:
28483994
20.

Global Distribution and Evolutionary History of Enterovirus D68, with Emphasis on the 2014 Outbreak in Ontario, Canada.

Eshaghi A, Duvvuri VR, Isabel S, Banh P, Li A, Peci A, Patel SN, Gubbay JB.

Front Microbiol. 2017 Mar 1;8:257. doi: 10.3389/fmicb.2017.00257. eCollection 2017.

21.

Evaluation of Altona Diagnostics RealStar Zika Virus Reverse Transcription-PCR Test Kit for Zika Virus PCR Testing.

L'Huillier AG, Lombos E, Tang E, Perusini S, Eshaghi A, Nagra S, Frantz C, Olsha R, Kristjanson E, Dimitrova K, Safronetz D, Drebot M, Gubbay JB.

J Clin Microbiol. 2017 May;55(5):1576-1584. doi: 10.1128/JCM.02153-16. Epub 2017 Mar 15.

22.

Draft Genome Sequences of Two "Haemophilus quentini" Isolates Recovered from Two Different Patients' Blood Cultures.

Eshaghi A, Soares D, Tsang R, Richardson D, Kus JV, Patel SN.

Genome Announc. 2016 Nov 23;4(6). pii: e01321-16. doi: 10.1128/genomeA.01321-16.

23.

Gray matter MRI differentiates neuromyelitis optica from multiple sclerosis using random forest.

Eshaghi A, Wottschel V, Cortese R, Calabrese M, Sahraian MA, Thompson AJ, Alexander DC, Ciccarelli O.

Neurology. 2016 Dec 6;87(23):2463-2470. Epub 2016 Nov 2.

24.

Fabrication of Fe-doped TiO2 nanoparticles and investigation of photocatalytic decolorization of reactive red 198 under visible light irradiation.

Moradi H, Eshaghi A, Hosseini SR, Ghani K.

Ultrason Sonochem. 2016 Sep;32:314-319. doi: 10.1016/j.ultsonch.2016.03.025. Epub 2016 Mar 29.

PMID:
27150776
25.

Spectrum of Viral Pathogens in Blood of Malaria-Free Ill Travelers Returning to Canada.

Kariyawasam R, Lau R, Eshaghi A, Patel SN, Sider D, Gubbay JB, Boggild AK.

Emerg Infect Dis. 2016 May;22(5):854-61. doi: 10.3201/eid2205.151875.

26.

A Perfect Storm: Impact of Genomic Variation and Serial Vaccination on Low Influenza Vaccine Effectiveness During the 2014-2015 Season.

Skowronski DM, Chambers C, Sabaiduc S, De Serres G, Winter AL, Dickinson JA, Krajden M, Gubbay JB, Drews SJ, Martineau C, Eshaghi A, Kwindt TL, Bastien N, Li Y.

Clin Infect Dis. 2016 Jul 1;63(1):21-32. doi: 10.1093/cid/ciw176. Epub 2016 Mar 29.

27.

Interim estimates of 2015/16 vaccine effectiveness against influenza A(H1N1)pdm09, Canada, February 2016.

Chambers C, Skowronski DM, Sabaiduc S, Winter AL, Dickinson JA, De Serres G, Gubbay JB, Drews SJ, Martineau C, Eshaghi A, Krajden M, Bastien N, Li Y.

Euro Surveill. 2016;21(11):30168. doi: 10.2807/1560-7917.ES.2016.21.11.30168.

28.

Mutations acquired during cell culture isolation may affect antigenic characterisation of influenza A(H3N2) clade 3C.2a viruses.

Skowronski DM, Sabaiduc S, Chambers C, Eshaghi A, Gubbay JB, Krajden M, Drews SJ, Martineau C, De Serres G, Dickinson JA, Winter AL, Bastien N, Li Y.

Euro Surveill. 2016;21(3):30112. doi: 10.2807/1560-7917.ES.2016.21.3.30112.

29.

Epidemiology of Enterovirus D68 in Ontario.

Peci A, Winter AL, Warshawsky B, Booth TF, Eshaghi A, Li A, Perusini S, Olsha R, Marchand-Austin A, Kristjanson E, Gubbay JB.

PLoS One. 2015 Nov 23;10(11):e0142841. doi: 10.1371/journal.pone.0142841. eCollection 2015.

30.

Vancomycin-Variable Enterococcal Bacteremia.

Downing MA, Xiong J, Eshaghi A, McGeer A, Patel SN, Johnstone J.

J Clin Microbiol. 2015 Dec;53(12):3951-3. doi: 10.1128/JCM.02046-15. Epub 2015 Sep 30.

31.

Genetic diversity and evolutionary insights of respiratory syncytial virus A ON1 genotype: global and local transmission dynamics.

Duvvuri VR, Granados A, Rosenfeld P, Bahl J, Eshaghi A, Gubbay JB.

Sci Rep. 2015 Sep 30;5:14268. doi: 10.1038/srep14268.

32.

Antibiotic susceptibility of clinical isolates of Campylobacter jejuni and Campylobacter coli in Ontario, Canada during 2011-2013.

Riley A, Eshaghi A, Olsha R, Allen VG, Patel SN.

Diagn Microbiol Infect Dis. 2015 Nov;83(3):292-4. doi: 10.1016/j.diagmicrobio.2015.07.020. Epub 2015 Jul 29.

PMID:
26320936
33.

Characterization of an Enterococcus gallinarum Isolate Carrying a Dual vanA and vanB Cassette.

Eshaghi A, Shahinas D, Li A, Kariyawasam R, Banh P, Desjardins M, Melano RG, Patel SN.

J Clin Microbiol. 2015 Jul;53(7):2225-9. doi: 10.1128/JCM.03267-14. Epub 2015 May 6.

34.

Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013-2014 Influenza Season.

Skowronski DM, Chambers C, Sabaiduc S, De Serres G, Winter AL, Dickinson JA, Gubbay J, Fonseca K, Charest H, Krajden M, Petric M, Mahmud SM, Van Caeseele P, Bastien N, Eshaghi A, Li Y.

J Infect Dis. 2015 Sep 1;212(5):726-39. doi: 10.1093/infdis/jiv177. Epub 2015 Mar 17.

PMID:
25784728
35.

First draft genome sequence of Aureimonas altamirensis, isolated from patient blood culture.

Eshaghi A, Shahinas D, Patel SN, Kus JV.

FEMS Microbiol Lett. 2015 Mar;362(6). pii: fnv016. doi: 10.1093/femsle/fnv016. Epub 2015 Feb 24.

PMID:
25714548
36.

Interim estimates of 2014/15 vaccine effectiveness against influenza A(H3N2) from Canada's Sentinel Physician Surveillance Network, January 2015.

Skowronski DM, Chambers C, Sabaiduc S, De Serres G, Dickinson JA, Winter AL, Drews SJ, Fonseca K, Charest H, Gubbay JB, Petric M, Krajden M, Kwindt TL, Martineau C, Eshaghi A, Bastien N, Li Y.

Euro Surveill. 2015 Jan 29;20(4). pii: 21022. No abstract available.

37.

Classification algorithms with multi-modal data fusion could accurately distinguish neuromyelitis optica from multiple sclerosis.

Eshaghi A, Riyahi-Alam S, Saeedi R, Roostaei T, Nazeri A, Aghsaei A, Doosti R, Ganjgahi H, Bodini B, Shakourirad A, Pakravan M, Ghana'ati H, Firouznia K, Zarei M, Azimi AR, Sahraian MA.

Neuroimage Clin. 2015 Jan 9;7:306-14. doi: 10.1016/j.nicl.2015.01.001. eCollection 2015.

38.

Vancomycin-variable enterococci can give rise to constitutive resistance during antibiotic therapy.

Thaker MN, Kalan L, Waglechner N, Eshaghi A, Patel SN, Poutanen S, Willey B, Coburn B, McGeer A, Low DE, Wright GD.

Antimicrob Agents Chemother. 2015 Mar;59(3):1405-10. doi: 10.1128/AAC.04490-14. Epub 2014 Dec 15.

39.

The role of cerebellar abnormalities in neuromyelitis optica--a comparison with multiple sclerosis and healthy controls.

Weier K, Eshaghi A, Magon S, Andelova M, Radue EW, Kappos L, Azimi AR, Sahraian MA, Sprenger T.

Mult Scler. 2015 May;21(6):757-66. doi: 10.1177/1352458514554051. Epub 2014 Dec 5.

PMID:
25480863
40.

Multiple influenza A (H3N2) mutations conferring resistance to neuraminidase inhibitors in a bone marrow transplant recipient.

Eshaghi A, Shalhoub S, Rosenfeld P, Li A, Higgins RR, Stogios PJ, Savchenko A, Bastien N, Li Y, Rotstein C, Gubbay JB.

Antimicrob Agents Chemother. 2014 Dec;58(12):7188-97. doi: 10.1128/AAC.03667-14. Epub 2014 Sep 22.

41.

Protective effects of Scutellaria lindbergii root extract against oxidative-induced cell and DNA damage in mouse fibroblast-like cells.

Ehtesham-Gharaee M, Eshaghi A, Shojaee S, Asili J, Emami SA, Behravan J, Mosaffa F.

Drug Chem Toxicol. 2015;38(3):293-9. doi: 10.3109/01480545.2014.954047. Epub 2014 Sep 19.

PMID:
25238169
42.

Coxsackieviruses in ontario, january 2005 to december 2011.

Peci A, Winter AL, Eshaghi A, Marchand-Austin A, Olsha R, Lombardi N, Gubbay JB.

Int J Infect Dis. 2014 Aug;25:136-41. doi: 10.1016/j.ijid.2014.04.013. Epub 2014 Jun 2.

43.

In vitro protective effects of Scutellaria litwinowii root extract against H2O2-induced DNA damage and cytotoxicity.

Shojaee S, Parhiz H, Eshaghi A, Emami SA, Asili J, Behravan J, Mosaffa F.

J Complement Integr Med. 2014 Jun;11(2):121-7. doi: 10.1515/jcim-2014-0009.

PMID:
24731956
44.

Low 2012-13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses.

Skowronski DM, Janjua NZ, De Serres G, Sabaiduc S, Eshaghi A, Dickinson JA, Fonseca K, Winter AL, Gubbay JB, Krajden M, Petric M, Charest H, Bastien N, Kwindt TL, Mahmud SM, Van Caeseele P, Li Y.

PLoS One. 2014 Mar 25;9(3):e92153. doi: 10.1371/journal.pone.0092153. eCollection 2014.

45.

Interim estimates of 2013/14 vaccine effectiveness against influenza A(H1N1)pdm09 from Canada s sentinel surveillance network, January 2014.

Skowronski D, Chambers C, Sabaiduc S, De Serres G, Dickinson J, Winter A, Fonseca K, Gubbay J, Charest H, Petric M, Krajden M, Mahmud S, Van Caeseele P, Kwindt T, Eshaghi A, Bastien N, Li Y.

Euro Surveill. 2014 Feb 6;19(5). pii: 20690. Erratum in: Euro Surveill. 2014;19(6):20698.

46.

Vancomycin-variable Enterococcus faecium: in vivo emergence of vancomycin resistance in a vancomycin-susceptible isolate.

Coburn B, Low DE, Patel SN, Poutanen SM, Shahinas D, Eshaghi A, Willey BM, McGeer A.

J Clin Microbiol. 2014 May;52(5):1766-7. doi: 10.1128/JCM.03579-13. Epub 2014 Feb 12.

47.

Outbreak of vancomycin-susceptible Enterococcus faecium containing the wild-type vanA gene.

Szakacs TA, Kalan L, McConnell MJ, Eshaghi A, Shahinas D, McGeer A, Wright GD, Low DE, Patel SN.

J Clin Microbiol. 2014 May;52(5):1682-6. doi: 10.1128/JCM.03563-13. Epub 2014 Feb 12.

48.

Genetic characterization of seasonal influenza A (H3N2) viruses in Ontario during 2010-2011 influenza season: high prevalence of mutations at antigenic sites.

Eshaghi A, Duvvuri VR, Li A, Patel SN, Bastien N, Li Y, Low DE, Gubbay JB.

Influenza Other Respir Viruses. 2014 Mar;8(2):250-7. doi: 10.1111/irv.12219. Epub 2013 Dec 6.

49.

Laboratory-confirmed influenza B infection in immunized long-term care facility residents receiving oseltamivir prophylaxis in Ontario.

Winter AL, Peci A, Eshaghi A, Baird M, Memari N, Kristjanson E, Balogun E, Higgins RR, Li A, Farrell DJ, Gubbay JB.

Infect Control Hosp Epidemiol. 2013 Nov;34(11):1225-8. doi: 10.1086/673455. Epub 2013 Sep 25.

PMID:
24113612
50.

Temporal and spatial evolution of grey matter atrophy in primary progressive multiple sclerosis.

Eshaghi A, Bodini B, Ridgway GR, GarcĂ­a-Lorenzo D, Tozer DJ, Sahraian MA, Thompson AJ, Ciccarelli O.

Neuroimage. 2014 Feb 1;86:257-64. doi: 10.1016/j.neuroimage.2013.09.059. Epub 2013 Oct 4.

Supplemental Content

Loading ...
Support Center